Economic evaluation in the context of rare diseases: is it possible?

  title={Economic evaluation in the context of rare diseases: is it possible?},
  author={Everton Nunes da Silva and T. R. Sousa},
  journal={Cadernos de saude publica},
  volume={31 3},
This study analyzes the available evidence on the adequacy of economic evaluation for decision-making on the incorporation or exclusion of technologies for rare diseases. The authors conducted a structured literature review in MEDLINE via PubMed, CRD, LILACS, SciELO, and Google Scholar (gray literature). Economic evaluation studies had their origins in Welfare Economics, in which individuals maximize their utilities based on allocative efficiency. There is no widely accepted criterion in the… CONTINUE READING
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Topics from this paper.


Publications referenced by this paper.

Challenges in the economic evaluation of orphan drugs

  • MF Drummond
  • Eurohealth
  • 2008
Highly Influential
9 Excerpts

Cleemput I. policies for orphan diseases and orphan drugs. non_com/docs/policies_orphan_en.pdf (accessed on 23/Mar/2013)

  • A Denis, S Simoens, C Fostier, L Mergaert
  • 2013

Enfermedades raras, huérfanas y olvidadas

  • D Rosselli, JD Rueda
  • pdf (accessed on…
  • 2013

background and proposed legislation in the 107th congress

  • Villarreal MA. Orphan Drug Act
  • http://…
  • 2013

os desafios da Europa

  • Direcção-Geral da Saúde e da Defesa do Consumidor, Comissão Europeia. Doenças raras
  • Consulta pública. Direcção C – Saúde pública e…
  • 2013

overview of rare disease activities in Europe

  • I European Union Committee of Experts on Rare Diseas part
  • 2013

understanding this public health priority

  • European Organisation for Rare Diseases. Rare diseases
  • 2013

How should we model rare disease allocation decisions

  • AJ London
  • Hastings Cent Rep
  • 2012

Similar Papers

Loading similar papers…